First Trust NYSE Arca Biotechnology Index Fund
235 hedge funds and large institutions have $921M invested in First Trust NYSE Arca Biotechnology Index Fund in 2021 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 61 increasing their positions, 83 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
235
Holders Change
–
Holders Change %
0%
% of All Funds
4.14%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
33
Increased
61
Reduced
83
Closed
30
Calls
$1.04M
Puts
$2.1M
Net Calls
-$1.06M
Net Calls Change
-$1.93M
Top Buyers
| 1 |
NA
Navellier & Associates
Reno,
Nevada
|
+$5.85M |
| 2 |
HF
HRT Financial
New York
|
+$5.49M |
| 3 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
+$4.86M |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$4.47M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$4.05M |
Top Sellers
| 1 |
LPL Financial
San Diego,
California
|
-$11.5M |
| 2 |
Morgan Stanley
New York
|
-$10.3M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.4M |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$4.37M |
| 5 |
IMC Chicago
Chicago,
Illinois
|
-$4.04M |
